MT Newswires4d agoneutral
Bernstein Adjusts Price Target on Vertex Pharmaceuticals to $620 From $608News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
106last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires5d agoneutral
Stifel Adjusts Price Target on Vertex Pharmaceuticals to $563 From $500MT Newswires5d agoneutral
Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $660 From $665MT Newswires5d agoneutral
Scotiabank Adjusts Price Target on Vertex Pharmaceuticals to $660 From $558MT Newswires5d agoneutral
Cantor Fitzgerald Adjusts Price Target on Vertex Pharmaceuticals to $619 From $595MT Newswires5d agoneutral
Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $725 From $654MT Newswires5d agoneutral
Barclays Adjusts Price Target on Vertex Pharmaceuticals to $626 From $617MT Newswires5d agoneutral
Wells Fargo Adjusts Price Target on Vertex Pharmaceuticals to $650 From $550MT Newswires5d agoneutral
BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $620 From $600MT Newswires5d agoneutral
TD Cowen Adjusts Price Target on Vertex Pharmaceuticals to $575 From $550MT Newswires5d agoneutral
JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $570 From $560MT Newswires96d agoneutral
Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says